Bret Christensen - 08 May 2023 Form 4 Insider Report for DermTech, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Mo Tashakor, attorney-in-fact
Issuer symbol
N/A
Transactions as of
08 May 2023
Net transactions value
$0
Form type
4
Filing time
10 May 2023, 20:02:19 UTC
Previous filing
01 Mar 2023
Next filing
07 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMTK Stock Option (right to buy) Award $0 +500,000 $0.000000 500,000 08 May 2023 Common Stock 500,000 $2.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continued service, (i) twelve thirty-sixths (12/36) of the shares of issuer common stock exercisable pursuant to this option shall vest on May 8, 2024 and (ii) the remaining twenty-four thirty-sixths (24/36) shall vest in a series of eight equal quarterly installments on the fifth day of each third month thereafter until the final vesting date on May 5, 2026.